Abstract
Aims
The objective of this study was to investigate sacral electrical stimulation (SES) and gastric electrical stimulation (GES) by comparing upper and lower gastrointestinal (GI) and genitourinary (GU) symptoms and quality of life, before treatment and in the long term after treatment. We hypothesized that dual-device treatment would greatly improve upper and lower gastrointestinal and genitourinary symptoms, as well as quality of life.
Methods
Fifty-four patients who underwent dual-device treatment (GES and SES) were enrolled in this study. Patients who had surpassed 24 months since the second-device insertion were included. Patients were evaluated before and after both devices were implanted and given a symptom questionnaire regarding their upper GI, lower GI, and GU symptoms and their quality of life.
Results
With combined treatment, a statistically significant improvement was seen in upper GI, lower GI, and GU symptoms and quality of life. However, fecal incontinence and fecal urgency improvements did not reach statistical significance, likely due to the small sample size.
Conclusion
The implantation of two stimulators appears to be safe and effective to improve patients’ quality of life for those with upper GI symptoms, bowel problems, and bladder dysfunction.
Similar content being viewed by others
References
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.
Creel WB, Abell L, Lobranao A, et al. To clot or not to clot: are there predictors of clinically significant thrombus formation in patients with gastroparesis and prolonged IV access? Dig Dis Sci. 2008;3:1532–1536.
Lahr CJ, Griffith J, Subamony C, Halley L. Gastric electrical stimulation for abdominal pain in patients with symptoms of gastroparesis. Am Surg.. 2013;79:457–464.
Bonapace ES, Davido S, Krevesky B, Fisher RS, Parkman HP. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J. Gastroenterol. 2000;95:2838–2847.
Caballeo-Plasencia AM, Valenzulea-Barranco M, Herrias-Gutierrez JM, Esteban-Carretero JM. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med. 1999;26:404–409.
Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1993;34:48–54.
Farup CE, Williams GR, Leidy NK, Helbers L, Mura M, Quigley EMM. Effect of domperidone on the health related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care. 1998;21:1699–1706.
Medtronics. What is a humanitarian device? 2015. Available from: http://www.medtronic.com/patients/gastroparesis/device/what-is-it/.
Abell TL. Gastric electric stimulation is a viable option in gastroparesis treatment. Nat Clin Pract Gastroenterol Hepatol. 2009;6:E8–E13.
O’Grady G, Egbuji JU, Du P, et al. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg. 2009;33:693–1701.
Leroi AM, Parc Y, Lehur PA. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg. 2005;242:662–669.
Van Kerebroeck PE, Van Voskuilen A, Cheesakkers JP. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029–2034.
Kohli N, Patteson D. Interstim® therapy: a contemporary approach to overactive bladder. Rev Obstet Gynecol. 2009;2:18–27.
Cutts TF, Luo J, Starkebaum W, Rashed H, Abell TL. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil.. 2005;17:35–43.
Carrington EV, Evers J, Grossi U, et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil. 2014;26:1222–1237.
Wald Arnold. New treatments for fecal incontinence: update for the gastroenterologist. Clin Gastroenterol Hepatol. 2014;12:1783–1788.
Patton V, Wiklendt L, Arkwright JW, et al. The effect of sacral neve stimulation on distal colonic motility in patients with faecal incontinence. Br J Surg. 2013;100:959–968.
Zhang J, Chen JD. Systematic review: application and future of gastric electrical stimulation. Aliment Pharmacol Ther. 2006;24:991–1002.
Acknowledgments
The authors would like to acknowledge the following people for their contribution to this study: Paige White, MD, Roger Dmochowski, MD, William Duncan, MD, Charles L Secrest, MD, John Brizzolara, MD, Howard Goldman, MD, Amar Al-Juburi, MD, Danielle Spree FNP, and Catherine McBride.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Abell has been a consultant, investigator, and licensor to Medtronic.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Agrawal, A., Francis, S.L., Deveneau, N.E. et al. Gastric Electrical Stimulation and Sacral Electrical Stimulation: A Long-Term Follow-Up Study of Dual-Device Treatment. Dig Dis Sci 61, 176–180 (2016). https://doi.org/10.1007/s10620-015-3840-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-015-3840-4